From: Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients
 |  |  | Follow-up month | ||||||
---|---|---|---|---|---|---|---|---|---|
Patient | Eyes | Baseline | 1 | 2 | 3 | 6 | 9 | 12 | 24 |
1 | OS | 1.56 | 1.52 | 1.30 | 1.30 | 1.30 | 1.52 | 1.80 | 1.90 |
OD | 1.58 | 1.52 | 1.34 | 1.52 | 1.52 | 1.60 | 1.60 | 1.30 | |
2 | OS | 1.30 | 1.30 | 1.20 | 1.30 | 1.20 | 1.30 | 1.30 | 1.32 |
OD | 1.30 | 1.30 | 1.30 | 1.20 | 1.30 | 1.30 | 1.30 | 1.16 | |
3 | OS | 1.00 | 1.00 | 1.00 | 0.80 | 0.80 | 0.80 | 0.80 | 1.00 |
OD | 0.80 | 0.80 | 0.80 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | |
4 | OS | 0.60 | 0.60 | 0.56 | 0.54 | 0.54 | 0.54 | 0.56 | 1.34 |
OD | 0.34 | 0.34 | 0.40 | 0.42 | 0.50 | 0.50 | 0.54 | 1.20 | |
5 | OS | 1.52 | 1.00 | 1.00 | 1.30 | 1.52 | 1.60 | 1.60 | 1.90 |
OD | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 1.18 | |
6 | OS | 1.30 | 1.00 | 1.00 | 1.13 | 1.26 | 1.30 | 1.30 | 1.15 |
OD | 0.40 | 0.30 | 0.30 | 0.50 | 0.40 | 0.50 | 0.50 | 0.70 | |
7 | OS | 2.00 | 2.00 | 2.00 | 2.00 | 1.90 | 2.00 | 2.00 | 2.00 |
OD | 1.90 | 1.90 | 1.90 | 1.90 | 1.70 | 2.00 | 1.90 | 1.90 | |
8 | OS | 0.92 | 0.90 | 0.90 | 0.92 | 0.92 | 0.92 | 0.90 | Â |
OD | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | Â |